Anti-Malaria HRP II Monoclonal Antibody (IgM) is a highly specific and sensitive antibody designed to target histidine-rich protein II (HRP II), a key biomarker of Plasmodium falciparum infection. This antibody is particularly valuable in diagnostic, research, and IVD manufacturing applications, where its specificity and rapid response capabilities make it essential for malaria detection and study. Its IgM isotype provides additional benefits in certain immunological applications due to its natural pentameric structure, enhancing antigen binding and detection.

Diagnostic Testing:
Used in ELISA, immunoassays, and rapid diagnostic tests to detect HRP II antigens in patient samples. Plays a vital role in identifying Plasmodium falciparum infections for accurate and timely malaria diagnosis.

Research & Development:
Supports studies on malaria pathogenesis, immune response to Plasmodium falciparum, and antigen-antibody interactions. Facilitates the development of innovative diagnostic tools and therapeutic approaches to combat malaria.

IVD Manufacturing:
Integral in the production of high-performance diagnostic kits designed for malaria detection. Ensures sensitivity and specificity in identifying HRP II antigens across diverse assay platforms, meeting clinical and laboratory requirements.